Strategic Management Track
C-Suite executives face unique challenges that are complicated and ever changing. Strategic management is an ongoing and critical process that identifies goals and prepares you, your team and your organization for every contingency. With the healthcare industry undergoing radical transformation, strategic management is more important than ever. In this track, emphasis will be given to innovative methods of addressing issues that impact healthcare executives, including industry consolidation, risk assessment, and future trends that are emerging.
1:00 pm – 2:15 pm Next Year Is Here: The Healthcare Supply Chain Market Outlook
Moderator: Bruce Carlson, Health Care Resource, Supply Chain, Materials Management, and Interim Staffing,
R B Carlson and Associates, LLC
Presenter: Mark Van Sumeren, Strategic Advisor, Medical Devices & Integrated Delivery Networks, Health Industry Advisor LLC
Healthcare continues to undergo seismic shifts in policy, payment, protocols and partnerships. Most IDNs and payers are moving steadily toward value-based care and managing the health of patient populations. Yet, tremendous uncertainty exists in the direction of healthcare policy and reimbursement. In the face of this uncertainty, the supply chain will continue to evolve along with the rest of the healthcare system in fulfilling the promise of change.
This session will review some of the major trends that will affect the supply chain in the coming 12 months, including:
- Assessing the impact of ACA, and the potential impact of AHCA, on healthcare costs, coverage and utilization. Moving beyond the political posturing, what good and bad, and what can be expected should "Repeal and Replace" succeed or fail?
- Reviewing how each sector of the healthcare ecosystem – providers, insurers, manufacturers – fared under ACA and since the surprise 2016 Presidential election. What does the current debate hold in store for these sectors?
- Have we as an industry made any progress in improving the healthcare supply chain?
- Identify the potential implications of the current healthcare financing debate on the demands of the healthcare industry, in general and supply chain in particular.
- Discuss how healthcare organizations have responded to the financing debate, and how Wall Street is judging their response.
- Analyze the rather weak industry response to-date in improving supply chain performance, despite overwhelming margin and financing pressures.
2:30 pm – 3:45 pm What Industry Consolidation in the Healthcare Supply Chain Means to You
Moderator: Francine Wilson, Senior Vice President Supply Chain Management, University Health System Business Center
Presenter: Eric O’Daffer, Research Vice President, Gartner
Mergers and acquisitions touch every area of the healthcare supply chain including Healthcare Providers, Manufacturers, Distributors and Group Purchasing Organizations. No matter where you sit in value chain, being aware of what is happening and formulating a strategy to optimize your organization’s reaction is critical. This workshop session highlights Gartner’s research on Industry Consolidation past and future with a focus on strategies to adapt to mergers and acquisitions and best practices if your organization is merging/acquiring. Learn from Gartner and your peers in this interactive session.
- Describe the factors that have resulted in an increase in mergers and acquisitions in healthcare.
- Analyze the impact that industry consolidation is having on healthcare supply chain.
- Identify strategies that you can use to ensure that a merger or acquisition creates value for your organization.
4:00 pm – 5:15 pm Supply Chain Risk Assessment: Pitfalls Abound
Moderator: Ed Hisscock, Vice President Clinical Sourcing and Informatics, Transformation Officer, Non-labor Spend
Presenters: Tony Benedict, Partner, Omicron Partners, LLC and Erich Heneke, MBA, CMA, CFE, Director, Business Integrity & Continuity, Mayo Clinic
As supply chain complexity grows and the supplier market becomes more competitive, critical suppliers may be in financial peril, which requires close monitoring of their viability. And others might be in leadership turmoil, litigation or investigations, posing a risk to IDNs. Meanwhile, having hundreds of vendor reps in health facilities every day, some of them not credentialed, also carries risk. Forward-looking providers understand that by closely linking supply chain and compliance functions, they can more efficiently and effectively comply with increasing regulatory demands, while enhancing patient safety, safeguarding patient privacy and protecting revenues.
In response, IDNs need to conduct a full risk assessment that includes:
- Identifying the most critical suppliers to monitor
- Examining current and historical financial data
- Analyzing governance issues, leadership changes, litigation and investigations
1. Outline the elements of a full risk assessment.
2. Devise a program through which supply chain and compliance can work together on risk issues.
3. Describe the elements of a risk management program.
All information is subject to change. Last updated 08/25/17.